Clinical Outcomes of a Customized Mitral Valve Plasty for Functional Mitral Regurgitation with a Low Ejection Fraction and Implications for Preoperative Right Ventricular Function

Autor: Hirohito Ishii, Kunihide Nakamura, Masanori Nishimura, Shuhei Sakaguchi, Mitsuhiro Yano, Kousuke Mori, Koji Furukawa
Rok vydání: 2021
Předmět:
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Mitral Valve Annuloplasty
Time Factors
subvalvular repair
030204 cardiovascular system & hematology
Risk Assessment
Ventricular Function
Left

03 medical and health sciences
0302 clinical medicine
papillary muscle approximation
Recurrence
Risk Factors
Internal medicine
Mitral valve
medicine
Humans
Hospital Mortality
restrictive mitral annuloplasty
Letter to the Editor
Mitral Annuloplasty
Functional mitral regurgitation
Aged
Retrospective Studies
Aged
80 and over

Ejection fraction
Ventricular Remodeling
Ventricular function
business.industry
Significant difference
Gastroenterology
Mitral Valve Insufficiency
Stroke Volume
General Medicine
Middle Aged
Treatment Outcome
medicine.anatomical_structure
030228 respiratory system
Fractional area change
Ventricle
Ventricular Function
Right

cardiovascular system
Cardiology
Female
Surgery
Cardiology and Cardiovascular Medicine
business
functional mitral regurgitation
Zdroj: Annals of Thoracic and Cardiovascular Surgery
ISSN: 2186-1005
1341-1098
DOI: 10.5761/atcs.oa.20-00035
Popis: PURPOSE To evaluate clinical outcomes of customized mitral valve plasty (MVP) for the treatment of functional mitral regurgitation (FMR) with a low ejection fraction (EF) and to determine which preoperative factors affected the clinical outcome. METHODS AND RESULTS MVP was adjusted according to the degree of left ventricle (LV) remodeling. We performed mitral annuloplasty (MAP) alone in 14 patients and added subvalvular procedures (SVPs) in 22 patients at a high risk of recurrent MR. During follow-up, reverse LV remodeling was obtained and the 3-year and 5-year non-recurrence rates of MR grade ≥2 were 94% and 89%, respectively. Two patients died during their hospital stay, and four more patients died of cardiac causes during follow-up. The 3-year and 5-year rates of freedom from cardiac-related mortality were 86% and 81%, respectively; no significant difference was observed between the two treatment groups. Right ventricular fractional area change (RVFAC) was a significant predictor of cardiac mortality. Patients with an RVFAC of
Databáze: OpenAIRE